GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and positive results for its Lipid inCode® test (“Lipid inCode®”) for hypercholesterolemia (high levels of cholesterol), including Familial Hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals (“RB&H”), recently merged with […]
The post Positive Results for Lipid inCode® in NHS Clinical Study first appeared on PR Business News Wire.
http://dlvr.it/SK0S7C
Subscribe to:
Post Comments (Atom)
MicroEsim Gaining Popularity: The Best eSIM for Europe Travel
MicroEsim is becoming the best eSIM for Europe travel, offering a seamless and flexible alternative to traditional SIM cards. With extensive...
-
ArtSmart, a 501(c)3 national nonprofit, announced today that it has received its first million-dollar donation over five years, given by Phi...
-
NCFR Annual Conference provides an opportunity to learn about the latest in research, practice, and teaching in the family field. You will g...
-
The U.S. Department of Commerce has added seven Chinese supercomputer makers to Entity List for their support to China’s military modernisat...
No comments:
Post a Comment